摘要
目的对雷贝拉唑联合莫沙必利应用于反流性食管炎治疗中的临床效果进行分析研究。方法选取于2014年2月~2015年6月经胃镜等临床检查确诊并且在我院接受治疗的反流性食管炎患者64例,并随机分为对照组（31例）和治疗组（33例）,观察法莫替丁联合莫沙必利与雷贝拉唑联合莫沙必利治疗的效果并比较。结果治疗组患者的治疗显效率为69.7%,治疗总有效率为93.9%,均高于对照组患者的38.7%和71.0%;同时治疗组患者的平均疼痛评分低于对照组,MUNSH评分高于对照组,组间数据经t检验,差异具有统计学意义（P〈0.05）。结论雷贝拉唑联合莫沙必利应用于反流性食管炎治疗中的临床效果确切。
Objective Combination treatment effect of Rabeprazole and Mosapride for reflux esophagitis is to be studied. Methods Choose 64 patients who were diagnosed to be reflux esophagitis by gastroscope in hospital from February 2014 to June 2015 and separated them into control group（31 patients）and study group（33 patients）at random,and then observe and compared the combination treatment effect of Famotidine and Mosapride or Rabeprazole and Mosapride between two groups. Results Patients＇ explicit efficiency and treatment efficacy in study group were 69.7% and 93.9% respectively,which were higher than counterparts of 38.7% and 71.0% in control group. Besides,patients＇ average pain grade in study group was lower and its MUNSH grade was higher than counterparts in control group,and there was a differential between two groups and such a differential had statistic value according to T-Check（P 0.05）. Conclusion Combination of Rabeprazole and Mosapride is effective in treatment of reflux esophagitis,it is worthwhile to be promoted widespread.
出处
《中国卫生标准管理》
2015年第21期62-63,共2页
China Health Standard Management
